SAMSCA (Otsuka America Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the SAMSCA drug offered from Otsuka America Pharmaceutical, Inc.. This Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Otsuka America Pharmaceutical, Inc.
NON-PROPRIETARY NAME: tolvaptan
SUBSTANCE NAME: TOLVAPTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-05-19
END MARKETING DATE: 0000-00-00


SAMSCA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSAMSCA from Otsuka America Pharmaceutical, Inc.
LABELER NAME: Otsuka America Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1)
START MARKETING DATE: 2009-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59148-020_fd141765-4d48-4b7e-aed1-3f2a72713c47
PRODUCT NDC: 59148-020
APPLICATION NUMBER: NDA022275

Other TOLVAPTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Otsuka America Pharmaceutical, Inc.SAMSCA